⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
CAPR News
Capricor Therapeutics Inc
CAPR Investor Alert: Kehoe Law Firm, P.C. Investigates Capricor Therapeutics After FDA Raises Concerns About Deramiocel Data
accessnewswire.com
CAPR
Capricor Therapeutics Investors Who Suffered Losses Are Encouraged to Contact Johnson Fistel
globenewswire.com
CAPR
CAPR INVESTOR ALERT: Investigation of Capricor Therapeutics, Inc. Announced by Holzer & Holzer, LLC
globenewswire.com
CAPR
BREAKING: Capricor Therapeutics Investigated for Securities Fraud by Block & Leviton; Investors Should Contact the Firm to Learn More
globenewswire.com
CAPR
Capricor Comments on Briefing Materials Ahead of July 29 FDA Advisory Committee Meeting for Deramiocel
globenewswire.com
CAPR
Duchenne Muscular Dystrophy Treatment Market Report (2025-2034) Published, Segments Intravenous, Subcutaneous, and Oral Routes Across Three Pharmacy Channels
globenewswire.com
SRPT
PFE
BIIB
REGN
GILD
JNJ
ABBV
NVS
SNY
CAPR
SLDB
WVE
EDIT
Form 8-K
sec.gov
CAPR
Form 8-K
sec.gov
CAPR
Capricor Therapeutics Announces FDA Advisory Committee Meeting to Review BLA for Deramiocel for the Treatment of Duchenne Muscular Dystrophy
globenewswire.com
CAPR
Capricor to Present Positive Five-Year HOPE-2 OLE Data and HOPE-3 Phase 3 Results for Deramiocel in Duchenne Muscular Dystrophy at PPMD 2026 Annual Conference
globenewswire.com
CAPR